Connecting with the Epilepsy Community
Upsher-Smith Laboratories, LLC is dedicated to enhancing the lives of those affected by epilepsy through robust awareness, education, and support programs. With events spanning from local gatherings to major national meetings, Upsher-Smith actively engages with patients, caregivers, and healthcare professionals.
Recent Events and Initiatives
One notable event was the Epilepsy Awareness Day at Disneyland, which brought together families and individuals impacted by this often misunderstood condition. Organized by the nonprofit Sofie's Journey, this event has transformed into a significant annual gathering. Upsher-Smith’s participation indicates their commitment to educating and uplifting families living with epilepsy.
During this gathering, Upsher-Smith showcased VIGAFYDE, a pioneering oral solution designed specifically for infants suffering from infantile spasms, an urgent medical condition. Their Promise of Support® Program further illustrates their dedication to providing comprehensive resources for healthcare providers, patients, and caregivers alike.
Infantile Spasms Awareness Week
Looking ahead, Upsher-Smith will continue its advocacy work by sponsoring the Eleventh Annual Infantile Spasms Awareness Week. This critical initiative, uniting numerous organizations, focuses on raising essential awareness about infantile spasms and emphasizes the unique challenges faced by affected families. Educating healthcare professionals about recognizing and treating this serious condition is a primary goal of the campaign.
Advancing Clinical Knowledge at Major Conferences
In addition to community events, Upsher-Smith actively participates in industry meetings, notably the American Epilepsy Society (AES) Annual Meeting. Scheduled for early December, this major event allows the company to connect with clinicians and discuss its expanding product line targeting rare diseases.
A prominent feature of their presence this year is a symposium titled "From Crisis to Care — Striving to Optimize Outcomes in Infantile Spasms." This session will delve deep into the challenges faced by families, exploring the journey from initial diagnosis to effective treatment plans. By involving leading experts, Upsher-Smith aims to promote comprehensive care strategies.
The Role of Education in Advocacy
Education remains a cornerstone of Upsher-Smith’s outreach efforts. The company recognizes that informed caregivers and healthcare professionals can drastically improve treatment outcomes for patients. By participating in educational panels and distributing critical information at events, Upsher-Smith fosters a collaborative environment that enhances understanding of epilepsy and infantile spasms.
Commitment to Patient Safety
Upsher-Smith prioritizes patient safety, particularly concerning VIGAFYDE. Governed by the rigorous Risk Evaluation and Mitigation Strategy (REMS) by the FDA, the company ensures that patients and their caregivers are well-informed about potential risks, particularly concerning vision health associated with its use.
As a crucial part of their program, Upsher-Smith facilitates regular vision screenings for young patients using VIGAFYDE, emphasizing the importance of early detection of any potential side effects. This approach underscores their dedication to patient well-being and ongoing support.
About Upsher-Smith Laboratories
As a member of Bora Group, Upsher-Smith Laboratories strives to be a trusted pharmaceutical partner. Their mission extends beyond product development; they're focused on enhancing the quality of life for patients globally. With a vast array of generics and brand-name products, Upsher-Smith's reputation for quality and reliability speaks volumes about its commitment to the healthcare community.
Frequently Asked Questions
What does Upsher-Smith do for the epilepsy community?
Upsher-Smith actively engages with the epilepsy community through events, educational programs, and awareness campaigns aimed at improving care and understanding.
What is VIGAFYDE used for?
VIGAFYDE is an oral solution designed to treat infants aged 1 month to 2 years who suffer from infantile spasms.
Why is awareness week important?
Infantile Spasms Awareness Week raises crucial awareness about a rare and serious condition, helping educate healthcare professionals and support affected families.
How does Upsher-Smith ensure patient safety?
The company implements the FDA-mandated REMS program for VIGAFYDE, which includes regular vision testing and thorough patient education on risks and benefits.
Where can I learn more about Upsher-Smith?
For more information, you can visit Upsher-Smith's official website where comprehensive details about their products and initiatives are available.
